Clinical Trials

35 enrolled

Phase 3 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT06955325 2025-05-06

UPLIFT

270 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02264210 2024-09-25

CORIN

128 enrolled 9 charts

Adenocarcinoma of Lung, Bronchial Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT01996098 2024-09-05

ICTAN

Phase 3 Terminated

251 enrolled

Lung Neoplasms

NCT06517953 2024-07-25

IcomBine

Phase 2 Recruiting

23 enrolled

Non-small Cell Lung Cancer Metastatic

NCT05514314 2022-08-24

A Multicenter Prospective Study to Assess the Effects of Adjuvant Icotinib in EGFRm Stage I NSCLC With High-risk of Disease Recurrence After Complete Resection

90 enrolled

Phase 2 Not yet recruiting

Carcinoma, Non-Small-Cell Lung

NCT05132985 2021-12-10

Neoadjuvant Icotinib With Chemotherapy for Epidermal Growth Factor Receptor(EGFR)-Mutated Resectable Lung Adenocarcinoma

45 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05104788 2021-11-03

NeoIpower

Phase 2 Recruiting

27 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02934256 2021-09-09

Icotinib

10 enrolled

CNS

Neuroma, Acoustic, Neurofibromatosis 2

NCT03736837 2021-03-15

ALTER-L004

Carcinoma, Non-Small-Cell Lung, Neoplasms

NCT04797806 2021-03-15

SAINT

Phase 3 Unknown

206 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02362230 2021-01-29

Evaluation of Icotinib in Metastatic Triple-negative Breast Cancer After Second-line Therapy

Phase 2 Terminated

26 enrolled

Breast

Breast Neoplasms

NCT02744664 2020-05-27

Cryotherapy Combine Icotinib for Advanced NSCLC Treatment

Phase 4 Completed

Lung Neoplasms

NCT03992885 2019-06-20

Clinical Study of Combination Therapy With Ectiecinib, Pemetrexed and Platinum in Patients With Metastatic Non-squamous Non-small Cell Lung Cancer With EGFR Mutations.

Phase 3 Unknown

70 enrolled

Non-squamous Non-small Cell Lung Cancer

NCT03983811 2019-06-12

Adjuvant Chemotherapy With or Without Intercalated Icotinib

Phase NA Unknown

174 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02889692 2019-04-11

Clinical Study of Chinese Medicine Plus Targeted Therapy Maintenance in Advanced Pulmonary Adenocarcinoma

Phase 3 Completed

23 enrolled

Lung Neoplasms, Neoplasms

NCT03766490 2019-01-30

Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer

Phase NA Unknown

66 enrolled

Non-Small-Cell Lung

NCT03151161 2018-06-07

Intermittent and Maintenance of Icotinib in Combination With Pemetrexed/Carboplatin Compared With Icotinib Single Drug in Ⅲb/IV Non Small Cell Lung Cancer With Epidermal Growth Factor Receptor (EGFR) Mutation

118 enrolled

Lung Neoplasms

NCT01534585 2018-04-17

Safety and Efficacy Study of Icotinib With Intensity-modulated Radiotherapy in Nasopharyngeal Carcinoma

Phase 1/2 Completed

48 enrolled

Head & Neck

Nasopharyngeal Carcinoma

NCT03153358 2017-05-16

Icotinib Combined With SBRT for Patients With Metastatic Non-squamous NSCLC With EGFR Mutation

Lung Neoplasms

NCT01963195 2017-05-08

Evaluation of the High Dose of Icotinib in Advanced Lung Cancer Patients After Failure of Target Therapy

30 enrolled

Drug-Related Side Effects and Adverse Reactions

NCT03123484 2017-04-21

β-elemene Combine With EGFR-TKI for Advanced EGFR-TKI-resistant NSCLC

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01724801 2017-03-01

BRAIN

Phase 3 Completed

176 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT02883543 2016-08-30

First-line Icotinib With Concurrent Radiotherapy for NSCLC With EGFR Mutation

Phase 3 Unknown

330 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02820116 2016-06-30

The Role of Icotinib in the Perioperative Treatment of IIIA - IIIB NSCLC Patients With EGFR Mutation

67 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02778893 2016-05-20

Conmana Combined With Thalidomide to Treat NSCLC

Phase 4 Unknown

67 enrolled

NSCLC

NCT02738983 2016-04-14

RT Plus EGFR-TKI for Wild-type NSCLC

22 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02031601 2016-03-29

TCL-1

Phase 4 Unknown

250 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02375581 2016-03-22

Phase II Study of Icotinib With Concurrent Radiotherapy in Elderly Patients With Esophageal Cancer

130 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT02430974 2015-04-30

Chemotherapy of NSCLC With or Without Icotinib

50 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02407366 2015-04-02

Icotinib With Concurrent Radiotherapy vs. Chemoradiotherapy in Non-small Cell Lung Cancer

80 enrolled

Carcinoma, Non-Small-Cell Lung

NCT02375022 2015-03-24

Rh-Endostatin in Combination With Icotinib for Advanced NSCLC With EGFR Mutations

10 enrolled

Lung Neoplasms

NCT02009605 2015-03-05

Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer

30 enrolled

Squamous Cell Carcinoma of Lung

NCT02283424 2014-11-05

Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation

Phase 4 Unknown

10 enrolled

Tumor-Agnostic

Neoplasms, Second Primary

NCT02272127 2014-10-22

Study of Chemotherapy Plus Icotinib to Treat EGFR Mutation-positive Non-small-cell Lung Cancer

100 enrolled

NSCLC

NCT02191059 2014-07-31

Phase II Clinical Study of Intermittent High Dose of Icotinib in Combination With Docetaxel to Treat Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT01514877 2014-07-23

Icotinib Combined With Whole Brain Radiotherapy in Treating Multiple Brain Metastases From Non-Small Cell Lung Cancer

20 enrolled

CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoplasm Metastasis

NCT01688713 2012-09-20

Phase II Trial of Double Dose of Icotinib in Treating Brain Metastases From Non-small Cell Lung Cancer